Efficacy and safety of pharmacotherapy for cancer cachexia: A systematic review and network meta‐analysis
Abstract Background Cancer cachexia affects more than half of all cancer patients, reducing survival rates. Evidence‐based approaches are urgently needed to optimize treatment. Methods A systematic review and network meta‐analysis were conducted to assess the effectiveness and safety of different ph...
Saved in:
Main Authors: | Hao Chen, Masashi Ishihara, Hiroki Kazahari, Ryusuke Ochiai, Shigeru Tanzawa, Takeshi Honda, Yasuko Ichikawa, Nobuyuki Horita, Hisashi Nagai, Kiyotaka Watanabe, Nobuhiko Seki |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-09-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.70166 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sarcopenia as a leading component of malignant cachexia syndrome
by: V. K. Lyadov, et al.
Published: (2012-02-01) -
Associations of cachexia and frailty with amyotrophic lateral sclerosis
by: Tracy L. Peters, et al.
Published: (2025-02-01) -
Sarcopenia and cachexia: molecular mechanisms and therapeutic interventions
by: Tiantian Wang, et al.
Published: (2025-01-01) -
Comparative Study on Associations Between Lung Cancer Prognosis and Diagnostic Criteria Set by the European Palliative Care Research Collaboration and the Asian Working Group for Cachexia
by: Utae Katsushima, et al.
Published: (2025-01-01) -
GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models
by: Yu Huang, et al.
Published: (2024-12-01)